Staging and restaging in the era of multimodality treatment

G. Ostoros (Budapest, Hungary)

Source: Annual Congress 2006 - Integrative approaches for stage III non-small cell lung cancer
Session: Integrative approaches for stage III non-small cell lung cancer
Session type: Hot topics
Number: 4592
Disease area: Thoracic oncology

Slide presentationMultimedia files

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
G. Ostoros (Budapest, Hungary). Staging and restaging in the era of multimodality treatment. Annual Congress 2006 - Integrative approaches for stage III non-small cell lung cancer

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Surgical multimodality treatment for stage III non-small cell lung cancer (NSCLC)
Source: Annual Congress 2006 - Integrative approaches for stage III non-small cell lung cancer
Year: 2006


Age and stage at presentation in lung cancer
Source: Annual Congress 2005 - Management of lung cancer: clinical problems
Year: 2005


Staging of lung cancer
Source: Eur Respir Mon; 2009: 44: 150–168
Year: 2009

Current surgical treatment of nonsmall cell lung cancer 2001
Source: Eur Respir J 2002; 19: 61S-70S
Year: 2002



Clonality of multifocal nonsmall cell lung cancer: implications for staging and therapy
Source: Eur Respir J 2012; 39: 1437-1442
Year: 2012



Neo-adjuvant chemotherapy: level of evidence in early stage and in marginally resectable disease
Source: Annual Congress 2005 - Multidisciplinary treatment of non-metastatic non-small cell lung cancer: contemporary concepts
Year: 2005

Radiotherapy in the treatment of nonsmall cell lung cancer
Source: Eur Respir Mon; 2009: 44: 207–243
Year: 2009

Chemotherapy in advanced nonsmall cell lung cancer
Source: Eur Respir Mon; 2009: 44: 271–283
Year: 2009

Prognostic impact of FDG-PET in recurrence of surgically treated non-small cell lung cancer
Source: Annual Congress 2005 - Management of lung cancer: clinical problems
Year: 2005


Extra-mediastinal FDG-PET hot-spots in a study of mediastinal staging of non-small cell lung cancer
Source: Eur Respir J 2004; 24: Suppl. 48, 458s
Year: 2004

Customising chemotherapy in advanced nonsmall cell lung cancer: daily practice and perspectives
Source: Eur Respir Rev 2011; 20: 45-52
Year: 2011



Integrated FDG-PET/CT for improved T and N staging of non-small-cell lung cancer
Source: Eur Respir J 2006; 28: Suppl. 50, 784s
Year: 2006

Is there any place for perioperative radiation therapy?
Source: Annual Congress 2005 - Multidisciplinary treatment of non-metastatic non-small cell lung cancer: contemporary concepts
Year: 2005

A novel biologic classification of non-small cell lung cancer
Source: Annual Congress 2005 - New insights into prognosis in thoracic surgical oncology
Year: 2005


Lung cancer
Source: Respipedia Article
Year: 2018

Imaging for staging stage III nonsmall cell lung cancer
Source: ISSN=ISSN 1810-6838, ISBN=, page=47
Year: 2007

Comparison of clinic and pathological staging in non-small cell lung cancer
Source: Annual Congress 2010 - Diagnostic and therapeutic problems in surgical oncology
Year: 2010


Preoperative FDG uptake on PET/CT predicts disease recurrence and survival in early stage non-small cell lung cancer (NSCLC)
Source: International Congress 2016 – Clinical aspects of lung cancer
Year: 2016


Should patients with metastatic NSCLC and poor performance status be treated by chemotherapy?
Source: Annual Congress 2007 - Treatment of metastatic nonsmall cell lung cancer in the era of targeted therapies
Year: 2007